Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients.
Flammia RS, Hoeh B, Hohenhorst L, Sorce G, Chierigo F, Panunzio A, Tian Z, Saad F, Leonardo C, Briganti A, Antonelli A, Terrone C, Shariat SF, Anceschi U, Graefen M, Chun FKH, Montorsi F, Gallucci M, Karakiewicz PI.
Flammia RS, et al. Among authors: anceschi u.
Int Urol Nephrol. 2022 Oct;54(10):2521-2528. doi: 10.1007/s11255-022-03250-0. Epub 2022 Jul 15.
Int Urol Nephrol. 2022.
PMID: 35838831
Free PMC article.